Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The sky is the limit for Welwyn Garden Heritage Trust presentation

Tuesday 19 March 2013, Welwyn Garden City LibraryThe birth of the Garden City – in pictures – is the treat in store at Welwyn Garden City’s recently refurbished library on Tuesday 19 March 2013, with the Welwyn Garden Heritage Trust joins forces with English Heritage, the library and Bryan Parkes to share aerial images – past and present – of the town. The evening event will give participants the chance to see aerial photographs of Welwyn Garden City taken in the 1920s and 1930s by Aerofilms, part of a new online library being created by English Heritage through the Britain from Above

Higher result for Lantmännen in the fourth quarter

Lantmännen’s financial result for the fourth quarter of 2012, after financial items and adjusted for items affecting comparability, amounted to 100 MSEK (5 MSEK). The improvement over last year is mainly due to higher earnings in the Energy Sector, and lower financial costs.The entire year-end report is available at https://lantmannen.com/en/about-lantmannen/financial-information/year-end-reports/ The result for the full year 2012, after financial items and adjusted for items affecting comparability, amounted to 565 MSEK (841 MSEK). The decrease is mainly attributable to the

Read original

Ericsson gives sneak peek into connected future

· During the Mobile World Congress in Fira Gran Via, Barcelona, between February 25-28, Ericsson will show what the Networked Society could look like by 2020 and beyond using demos of 5G, the Connected Megacity and Window of Opportunity · 5G for the Networked Society beyond 2020 -  Ericsson's take on how to manage 50 billion connections in a sustainable and cost efficient way · The Connected Megacity - a demo showing how ICT can increase safety, creativity and sustainability in cities that by 2050 will be occupied by 70 percent of the world population · Window of Opportunity -

Electrosonic to Exhibit at the Russian Association of Amusement Parks and Attractions Expo (RAAPA) in Moscow

London (February 22, 2013) – Electrosonic will be exhibiting for the first time at the 15th Russian Association of Amusement Parks and Attractions Expo (RAAPA) in Moscow on 20-22 March at stand A7/3. Electrosonic’s entertainment business provides a complete set of audio-visual services, including custom designed audio, video and control systems, systems integration and full project management, plus a range of on and off site services and maintenance offerings. Custom solutions are provided for museums, visitor centres, theme parks, water parks and family entertainment centres. Clients

Hyundai to debut Grand Santa Fe to European audience at 2013 Geneva Motor Show

· Grand Santa Fe premium six- or seven-seat SUV makes European debut · Ride and handling tailored for European consumers · Longer wheelbase offers more space, including class-leading cargo capacityOffenbach, 22 February 2013 At the 2013 Salon International de l'Auto in Geneva, Hyundai will unveil its Grand Santa Fe – the company’s E-segment extended wheelbase SUV. Joining the already-successful New Generation Santa Fe, the new model further demonstrates Hyundai’s SUV expertise and heritage. To meet the region’s demand for a long wheelbase version, Grand Santa Fe was designed

Global Health Partner enters into an exclusive agreement with Team Danmark

Through its subsidiary Gildhøj Privathospital, Global Health Partner (GHP) is entering into an exclusive collaboration agreement with Team Danmark to provide Denmark’s leading elite athletes with sports medicine and sports surgery. “The collaboration with Team Danmark is confirmation that Gildhøj Privathospital is one of Denmark’s leading sports clinics,” says Marianne Dicander Alexandersson, CEO of Global Health Partner.Gildhøj Privathospital is one of Denmark’s best reputed private hospitals and was founded in 1991. Gildhøj is situated in the outskirts of Copenhagen and works in the

Rays of light in the Swedish economy

The Economic Tendency Indicator climbed almost five points from 89.9 in January to 94.7 in February. It is now slightly more than five points below the historic average, and indicates that growth in the Swedish economy is still weaker than normal. Manufacturing and the private service sector made a positive contribution this month, while the results from the construction industry and the retail trade were neutral. The Consumer Confidence Indicator improved further in February.Confidence indicator for industry as a whole climbs for a third successive month The confidence indicator for the

Summary of year-end report 2012 [1]

Successful first full year as a Gold Mining and Exploration Company Highlights Q4/2012 · Record gold production 277.4 kg (183.7), + 51%Endomines was granted a 3.8 MSEK investment subsidy for the capacity expansion at the Pampalo Gold Mine · Revenues 74.4 MSEK (35.6), +109%- EBITDA before unrealized loss on derivatives 31.6 MSEK (-4.2) · Operating result 30.0 MSEK (-14.0) · Profits after tax from continued operations 24.7 MSEK (-17.8) · Earnings per share from continued operations 0.31 SEK (-0.22) · Cash funds at end-of-year 69.0

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act. The list is based on reports received by H. Lundbeck A/S from the company's executives today or yesterday. Name: Melanie Georgina LeeJob position of the executive: Board memberID code (ISIN code): DK 0010287234Description of the security:

Regulatory Application has now been filed for Simeprevir (TMC435) in Japan for the treatment of genotype 1 hepatitis C patients

Stockholm, Sweden — Medivir AB (OMX: MVIR) today announced that its partner Janssen now has submitted a regulatory application to the Japanese Ministry of Health & Welfare authorities seeking approval for simeprevir, administered with pegylated interferon (Peg-IFN) and ribavirin (RBV) for the treatment of genotype 1 chronic hepatitis C patients who are treatment naïve, prior non responders or relapsed following treatment with Peg-IFN with or without RBV. Simeprevir, an investigational NS3/4A protease inhibitor, is administered as a single once-daily pill for 12 weeks. The regulatory

Aker ASA: Fourth quarter results 2012: Net Asset Value of NOK 22.9 billion

The Net Asset Value of Aker ASA and its holding companies (Aker) was NOK 22.9 billion as of 31 December 2012, compared to NOK 23.3 billion as of 30 September 2012 and NOK 19.4 billion as of 31 December 2011."Aker delivered strong financial results in 2012,'' Aker's President and CEO Øyvind Eriksen said.  "Our net asset value rose 18 per cent to NOK 22.9 billion in the year, the strongest advance since 2006. The company's market value increased 44 per cent in the period, including dividend.  As a result of this, Aker's share discount to NAV narrowed to a four-year low of 34 per cent as per

Year-end report 2012

Fourth quarter 2012 · Net asset value fell by 5.6 per cent during the quarter and amounted to SEK 27.1 per share. · Vitrolife hived off the company Xvivo Perfusion AB– a new holding in Bure’s portfolio. · Impairment losses recognised for a total of SEK 140M in the portfolio companies Mercuri International and Theducation. · Bure purchased shares in Vitrolife for SEK 3.8M and acquired additional shares in the Life Science company MedCap for SEK 4.5M. · Consolidated earnings per share totalled SEK -0.79 (0.92). Full year January – December 2012 · Net asset value per

Year-end report 2012: Satisfactory annual results - maintaining fast paced conversion efforts

October - December 2012 · Net sales totaled SEK 10,481m (10,528). · Operating profit totaled SEK 122m (645). · Adjusted operating profit, excluding restructuring costs and non-recurring effects, totaled SEK 549m (666). · Net profit totaled SEK 72m (441). · Operating margin was 1.2 (6.1) % and adjusted operating margin was 5.2 (6.3) %. · Cash flows from operating activities totaled SEK 1,256m (1,324). · Lars Idermark announced that he will step down as President and CEO. January - December 2012 · Net sales totaled SEK 38,920m (39,466). · Operating profit

Financial Statement, 1 January – 31 December 2012*

Full-year (January − December) · Net turnover totalled SEK 555.0 million (SEK 698.6 m). · The profit/loss after tax was SEK -219.1 million (SEK 113.8 m). · Basic and diluted earnings per share totalled SEK -7.01 (SEK 3.80). · The cash flow from operating activities amounted to SEK -139.5 million (SEK 57.3 m), while liquid assets and short-term investments totalled SEK 296.7 million (SEK 536.3 m) at the period end. · Phase III trials of simeprevir or telaprevir in combination with pegylated interferon and ribavirin began. · Two interferon-free phase II combination trials

Unique continuous processing pharmaceutical production line to be introduced in Finland

PROMIS Centre, a research centre focused on the development of methods for analysis and optimisation of pharmaceutical processes, has built a new and unique continuous processing pharmaceutical production line – the only one of its kind in Europe. The production line was created for R&D purposes, but it also caters for the needs of the pharmaceutical industry, as continuous processing offers possibilities to increase cost-efficiency in pharmaceutical manufacturing. Based in the city of Kuopio, PROMIS Centre is a multidisciplinary research consortium involving the University of Eastern

EXELIXIS SELECTS SWEDISH ORPHAN BIOVITRUM AB AS COMETRIQ (TM) EUROPEAN DISTRIBUTOR FOR MEDULLARY THYROID CANCER

Contact:Charles ButlerVice President, Investor Relations and Corporate CommunicationsExelixis, Inc.(650) 837-7277cbutler@exelixis.com Anders EdvellVice President, Sobi Partner Products, Sobi+46 8 697 2000anders.edvell@sobi.com Jörgen WinrothVice President, Investor Relations, Sobi+46 8 697 3427jorgen.winroth@sobi.com South San Francisco, CA and Stockholm, Sweden - February 22, 2013 - Exelixis,Inc. (NASDAQ:EXEL) and Swedish Orphan Biovitrum (Sobi) (STO: SOBI) todayannounced that they have entered into a three-year agreement to support thedistribution and commercialization of

Exercising of share options

Olof Milveden, CFO of Navamedic ASA, has on 22 February 2013 exercised 50,000 stock options at an average price of NOK 7.31 per share. Number of stock options held after the transaction are 50,000 at conditions as previously announced, and number of shares held once the transaction has effectively been completed are 187,000. For further information, please contact: Navamedic ASA CFO Bjørn Lindholt Tel: +47 930 06601 This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Year-end Report 2012

Fourth Quarter (October – December 2012) · Capitalized exploration costs for the fourth quarter amounted to 1.3 (3.2) mkr  · P/L after tax for the fourth quarter totaled -0.7 (-.6) mkr  · P/L per share for the fourth quarter totaled -0.07 (-0.19) kr Full year (January – December 2012) · Capitalized exploration costs for the full year amounted to 4.8 (15.9) mkr  · P/L after tax for the full year totaled -4.8 (-6.6) mkr  · P/L per share for the full year totaled -0.45 (-0.83) kr  · Equity per share at December 31, 2012 was 5.41 (5.86) kr3) kr  · The mineral

Managed Services Providers need to rethink their relationship with Communication Service Providers to deliver true business value

Tecnotree CorporationPress Release22 February, 2013 at 8.15 am CET  Barcelona, Spain – Telecom IT solutions provider Tecnotree today released a whitepaper outlining competitive advantages of the new Managed Services delivery model for the Communication Service Providers. The new Managed Services refers to the practice of outsourcing day-to-day IT management responsibilities of mission critical Business Support Systems to a service provider. The model introduces a completely new mindset for the relationship between CSPs and Managed Services Providers. The focus shifts from value

Year-end Report 2012

Continued growth in clinical sales, +55% in the fourth quarter supported by US operations and signed distribution agreements in key regions.January – December 2012 · Global Net sales grew by 57% to SEK 147.0m (93.5)* of which SEK 35.7m (15.5) were strategic sales (sales to Pharmaceutical companies and CRO’s for clinical trials). Adjusted for currency fluctuations, net sales rose by 56% Year over Year (Y-o-Y). · The worldwide number of NIOX MINO® repeat tests sold increased in total by 35%; repeat tests for clinical use in the US grew by 54%. Total number of tests sold (repeat and

YEAR-END REPORT 2012

Fourth quarter · Rental revenue SEK 6.6 M (6.5) · Operating profit SEK 228.6 M (12.3) · Profit before tax SEK 226.8 M (10.1) · Unrealized changes in property value SEK 224.6 M (9.2) · Investments in remaining operations SEK 0.3 M (0.8) · Profit after tax SEK 192.1 M (6.1), corresponding to SEK 16.61 per share (0.53) The period January-December · Rental revenue SEK 26.6 M (27.0) · Operating profit SEK 255.3 M (94.5) · Profit before tax SEK 246.5 M (90.7) · Unrealized changes in property value SEK 238.5 M (86.7) · Investments in remaining operations SEK

There are no items matching the current filter
There are no more items matching the current filter
Back to top